Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.
D000284:Administration, Oral; D001120:Arginine / Q000008:administration & dosage; D001786:Blood Glucose / Q000032:analysis; D003510:Cyclohexanes / Q000008:administration & dosage / Q000494:pharmacology; D004341:Drug Evaluation; D005260:Female; D005934:Glucagon / Q000097:blood / Q000378:metabolism*; D005905:Glyburide / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D008297:Male; D008722:Methods; D010179:Pancreas / Q000187:drug effects; D011719:Pyrazines / Q000008:administration & dosage / Q000494:pharmacology; D013453:Sulfonylurea Compounds / Q000008:administration & dosage* / Q000494:pharmacology
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D011719:Pyrazines; D013453:Sulfonylurea Compounds; D005934:Glucagon; D001120:Arginine; D005905:Glyburide